Archana Aggarwal, MD
Nephrology · San Leandro
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 20
- 5 carriers
- Office
- 1
Offices
1 location · West Coast Kidney · 56 clinicians in this group
Looking this up.
Hospitals listed: 052685 · 552600 · 752527 · Eden Medical Center · Highland Hospital. That is not proof they admit you there this week.
Plans that list them
20 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Aggarwal’s office at (510) 351-9373 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
20 of 20 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A74682 · Current
Licensed to practise in California · since 2001 · expires 2027-02-28 · Howard University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
- Highland HospitalOakland, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Alameda Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.568, Oct 2024 – Sep 2025
See every measure and the patient survey for Eden Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.122 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 819 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.46 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.41 (92.94 to 181.88) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,714 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 4,676 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 860 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.17 to 4.32) · 818 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.76 (0 to 15.78) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.12) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,132 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 60 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.307 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.4 · 367 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 390 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.4) · 68 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 205 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Highland Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 5 the same, 1 worse of 6 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.568 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 487 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.7 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.35 (145.43 to 251.26) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 83 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.3 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.9 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 68 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 1,143 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.38) · 4,370 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.47) · 4,344 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.54 (0.29 to 4.79) · 689 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.07 (0.37 to 3.78) · 165 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.91 (0.34 to 3.48) · 681 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.62 (2.72 to 20.53) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.44 (1.37 to 9.5) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.97 (0.49 to 3.45) · 126 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.76 (0.07 to 1.44) · 3,387 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.519 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.682 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 51 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 184 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 141.8 · 59 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 27.6 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 35.3 · 253 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 243 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.2 to 7.7) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (9.7 to 18.5) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.4 (10.8 to 19.4) · 355 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 84 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,960 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
Original Medicare doctor bills
$275,280
Medicare paid this office $275,280 for 478 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 63 | $111,573 | $315 |
| Return visit (30+ min) | 152 | $38,527 | $108 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 52 | $22,119 | $263 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 167 | $20,351 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 102 | $20,217 | $104 |
See all 12 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 63 | $111,573 | $315 |
| Return visit (30+ min) | 152 | $38,527 | $108 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 52 | $22,119 | $263 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 167 | $20,351 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 102 | $20,217 | $104 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 112 | $13,135 | $114 |
| Hemodialysis procedure with physician evaluation | 72 | $8,380 | $63 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 21 | $5,328 | $59 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 133 | $3,882 | $15 |
| New patient visit (45+ min) | 25 | $3,521 | $141 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | $3,085 | $86 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 21 | $2,346 | $46 |
Who their Medicare patients are
478 Original Medicare patients in 2024. Average age 73 · Under 65 18% · 85 and older 17% · Women 49% · Also on Medicaid 58% · Health risk score 4.88. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 69% · Heart failure 53% · Coronary heart disease 45% · Atrial fibrillation 32% · Depression 29% · COPD 26% · Stroke 26% · Dementia 22% · Cancer 14%.
The office billed $725,487, Medicare allowed $353,904 and paid $275,280; for 2,230 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 478 | 2,230 | 73 | 4.88 | $725,487 | $275,280 |
| 2023 | 483 | 2,054 | 73 | 4.94 | $707,118 | $279,314 |
| 2022 | 481 | 1,978 | 72 | 4.73 | $619,701 | $237,005 |
| 2021 | 418 | 1,742 | 73 | 4.05 | $624,638 | $248,318 |
| 2020 | 395 | 1,593 | 72 | 4.45 | $531,508 | $208,229 |
| 2019 | 422 | 1,816 | 72 | 4.44 | $580,140 | $221,277 |
| 2018 | 414 | 1,928 | 72 | 4.71 | $590,078 | $224,152 |
| 2017 | 424 | 2,089 | 72 | 4.91 | $556,655 | $207,183 |
| 2016 | 401 | 2,728 | 72 | 4.80 | $665,195 | $251,857 |
| 2015 | 437 | 3,281 | 71 | 5.08 | $692,004 | $266,636 |
| 2014 | 385 | 3,173 | 73 | 4.35 | $626,501 | $246,455 |
| 2013 | 413 | 3,655 | 72 | 4.84 | $628,990 | $252,058 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 63 | $117,676 | $319 |
| Return visit (30+ min) | 151 | $38,991 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 127 | $28,064 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 182 | $25,527 | $71 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 33 | $13,017 | $266 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 88 | $10,971 | $117 |
| Hemodialysis procedure with physician evaluation | 79 | $7,748 | $64 |
| Long return visit (40+ min) | 23 | $5,646 | $161 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $3,934 | $157 |
| New patient visit (45+ min) | 27 | $3,861 | $143 |
| Telephone medical discussion with physician, 11-20 minutes | 28 | $3,056 | $87 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $2,218 | $117 |
| Dialysis services, per day, less than full month service (20 years or older) | 13 | $1,580 | $9 |
2022: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 50 | $89,112 | $318 |
| Return visit (30+ min) | 131 | $31,949 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 212 | $27,414 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 111 | $22,321 | $91 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 122 | $16,154 | $119 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 32 | $14,007 | $255 |
| Hemodialysis procedure with physician evaluation | 93 | $12,413 | $64 |
| Long return visit (40+ min) | 20 | $4,318 | $160 |
| New patient visit (45+ min) | 30 | $3,766 | $126 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,822 | $176 |
2021: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 50 | $110,003 | $319 |
| Return visit (30+ min) | 115 | $28,766 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 121 | $23,904 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 176 | $23,186 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 88 | $12,540 | $123 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 24 | $10,368 | $266 |
| Long return visit (40+ min) | 35 | $7,263 | $161 |
| Hemodialysis procedure with physician evaluation | 49 | $6,689 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,083 | $182 |
| New patient visit (45+ min) | 16 | $2,451 | $153 |
2020: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 40 | $89,136 | $263 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 175 | $26,353 | $66 |
| Return visit (30+ min) | 119 | $23,796 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $16,062 | $95 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 43 | $15,438 | $224 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 100 | $14,000 | $125 |
| Hemodialysis procedure with physician evaluation | 60 | $6,861 | $67 |
| New patient visit (45+ min) | 18 | $2,815 | $156 |
| Long return visit (40+ min) | 21 | $2,603 | $104 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,423 | $186 |
2019: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 39 | $92,511 | $254 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 201 | $28,096 | $63 |
| Return visit (30+ min) | 126 | $22,977 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 111 | $22,298 | $91 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 110 | $15,057 | $120 |
| Long return visit (40+ min) | 48 | $10,785 | $125 |
| Hemodialysis procedure with physician evaluation | 73 | $8,190 | $63 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 21 | $6,140 | $212 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,594 | $180 |
| New patient visit (45+ min) | 21 | $3,105 | $148 |
2018: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 47 | $91,152 | $250 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 183 | $28,464 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 124 | $24,036 | $92 |
| Return visit (30+ min) | 95 | $17,555 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 116 | $15,527 | $120 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 32 | $10,781 | $216 |
| Hemodialysis procedure with physician evaluation | 86 | $10,288 | $63 |
| Long return visit (40+ min) | 35 | $8,253 | $127 |
| Critical care, first 30-74 minutes | 13 | $3,106 | $194 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,061 | $180 |
| New patient visit (45+ min) | 11 | $1,663 | $151 |
2017: 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 44 | $89,754 | $245 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 189 | $22,459 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 93 | $14,791 | $91 |
| Return visit (30+ min) | 97 | $14,484 | $81 |
| Long return visit (40+ min) | 46 | $10,144 | $115 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 32 | $9,374 | $208 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 67 | $9,181 | $119 |
| Hemodialysis procedure with physician evaluation | 76 | $8,016 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,551 | $177 |
2016: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 68 | $112,185 | $240 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 107 | $24,382 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 102 | $20,123 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 150 | $20,088 | $62 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 41 | $14,706 | $207 |
| Return visit (30+ min) | 87 | $11,760 | $81 |
| Long return visit (40+ min) | 47 | $10,314 | $115 |
| Critical care, first 30-74 minutes | 18 | $7,251 | $186 |
| Hemodialysis procedure with physician evaluation | 56 | $5,932 | $62 |
| New patient visit (45+ min) | 11 | $1,601 | $146 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,289 | $117 |
| Dialysis services, per day, less than full month service (20 years or older) | 11 | $866 | $5 |
| Manual urinalysis test with examination using microscope, non-automated | 24 | $106 | $4 |
2015: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 70 | $131,494 | $248 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 129 | $23,510 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 102 | $20,241 | $172 |
| Return visit (30+ min) | 101 | $16,541 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 139 | $15,292 | $62 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 39 | $11,292 | $209 |
| Long return visit (40+ min) | 42 | $8,743 | $127 |
| Critical care, first 30-74 minutes | 18 | $6,262 | $184 |
| Hemodialysis procedure with physician evaluation | 59 | $5,666 | $62 |
| Dialysis services, per day, less than full month service (20 years or older) | 14 | $2,101 | $7 |
| Hemodialysis procedure requiring repeated evaluation | 11 | $1,165 | $90 |
2014: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 66 | $118,117 | $247 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 122 | $25,202 | $174 |
| Return visit (30+ min) | 97 | $21,089 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 152 | $18,576 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 106 | $17,858 | $89 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 31 | $9,613 | $209 |
| Hemodialysis procedure with physician evaluation | 51 | $6,558 | $62 |
| Long return visit (40+ min) | 22 | $4,472 | $128 |
| New patient visit (45+ min) | 15 | $2,184 | $146 |
| Manual urinalysis test with examination using microscope, non-automated | 12 | $59 | $4 |
2013: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 68 | $113,311 | $244 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 176 | $24,684 | $60 |
| Return visit (30+ min) | 97 | $21,822 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 111 | $21,235 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 118 | $20,143 | $87 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 23 | $8,689 | $207 |
| Hemodialysis procedure with physician evaluation | 84 | $8,451 | $61 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 16 | $7,424 | None |
| Long return visit (40+ min) | 26 | $4,717 | $124 |
| Critical care, first 30-74 minutes | 14 | $3,692 | $185 |
| Injection of drug or substance under skin or into muscle | 18 | $955 | $24 |
Medicaid work
$129,361 in 2024
Medicaid paid $129,361 for 1,148 billed services this clinician did in 2024, up to 49 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 394 | $81,997 |
| Return visit (30+ min) | 209 | $16,480 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 224 | $8,493 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 109 | $7,314 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 36 | $7,096 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 63 | $4,062 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 113 | $3,918 |
| 2024 | 1,148 | 7 | 49 | $129,361 |
| 2023 | 1,090 | 7 | 38 | $107,586 |
| 2022 | 1,242 | 7 | 35 | $90,485 |
| 2021 | 2,577 | 8 | 34 | $54,802 |
| 2020 | 935 | 6 | 34 | $44,565 |
| 2019 | 926 | 6 | 36 | $53,766 |
| 2018 | 3,478 | 8 | 34 | $54,846 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 386 | $74,724 |
| Return visit (30+ min) | 187 | $10,964 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 164 | $8,259 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 245 | $8,066 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 68 | $2,593 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 28 | $2,202 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 12 | $779 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 300 | $54,101 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 422 | $11,177 |
| Return visit (30+ min) | 131 | $7,642 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 222 | $6,841 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 27 | $4,966 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 122 | $4,512 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 18 | $1,246 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 340 | $41,696 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 355 | $7,536 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 180 | $3,598 |
| Injection, doxercalciferol, 1 mcg | 353 | $627 |
| Return visit (30+ min) | 13 | $613 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 19 | $392 |
| Iron sucrose injection | 85 | $340 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 1,232 | $0 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 335 | $33,831 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 269 | $6,432 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 69 | $2,145 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 27 | $2,023 |
| Injection, doxercalciferol, 1 mcg | 91 | $134 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 144 | $0 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 392 | $38,807 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 335 | $7,090 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 138 | $4,985 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 34 | $1,383 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 14 | $1,242 |
| Return visit (30+ min) | 13 | $259 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 359 | $37,103 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 346 | $6,514 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 164 | $4,449 |
| Injection, doxercalciferol, 1 mcg | 1,076 | $4,248 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 61 | $2,004 |
| Iron sucrose injection | 52 | $358 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 12 | $171 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 1,408 | $0 |
Drugs they prescribed that Part D paid
$213,980
Pharmacies billed $213,980 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,028) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
928 generic and 100 brand-name prescriptions · $213,980 in drug cost · 17 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Velphoro | 14 | $64,545 | $4,610 |
| Lokelma | 32 | $49,867 | $1,558 |
| Kerendia | 12 | $19,655 | $1,638 |
| Cinacalcet | 14 | $9,293 | $664 |
| Sevelamer Carbonate | 26 | $8,028 | $309 |
See all 24 drugs
| Velphoro | 14 | $64,545 | $4,610 |
| Lokelma | 32 | $49,867 | $1,558 |
| Kerendia | 12 | $19,655 | $1,638 |
| Cinacalcet | 14 | $9,293 | $664 |
| Sevelamer Carbonate | 26 | $8,028 | $309 |
| Calcium Acetate | 26 | $2,910 | $112 |
| Losartan | 139 | $1,251 | $9 |
| Bumetanide | 15 | $724 | $48 |
| Hydralazine | 33 | $587 | $18 |
| Amlodipine Besylate | 108 | $558 | $5 |
| Calcitriol | 24 | $551 | $23 |
| Tacrolimus | 11 | $502 | $46 |
| Nifedipine Er | 14 | $494 | $35 |
| Furosemide | 92 | $490 | $5 |
| Metolazone | 16 | $452 | $28 |
| Lisinopril | 53 | $384 | $7 |
| Tamsulosin | 27 | $368 | $14 |
| Carvedilol | 50 | $366 | $7 |
| Spironolactone | 34 | $295 | $9 |
| Allopurinol | 29 | $235 | $8 |
| Gabapentin | 14 | $117 | $8 |
| Clonidine | 20 | $77 | $4 |
| Prednisone | 11 | $58 | $5 |
| Atorvastatin | 13 | $17 | $1 |
Year by year
| 2024 | 1,028 | 158 | 0% (0) | 10% | $213,980 |
| 2023 | 957 | 150 | None | 12% | $175,471 |
| 2022 | 963 | 131 | 0% (0) | 12% | $148,442 |
| 2021 | 1,006 | 140 | 0% (0) | 10% | $174,365 |
| 2020 | 1,055 | 123 | 0% (0) | 11% | $131,618 |
| 2019 | 1,195 | 122 | 0% (0) | 13% | $169,420 |
| 2018 | 1,740 | 127 | 0% (0) | None | $247,452 |
| 2017 | 2,089 | 139 | None | 23% | $472,835 |
| 2016 | 1,907 | 138 | None | 26% | $441,997 |
| 2015 | 2,035 | 141 | None | 29% | $520,251 |
| 2014 | 1,985 | 155 | None | None | $427,852 |
| 2013 | 2,015 | 143 | None | None | $314,860 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Lokelma | 20 | $32,728 | $1,636 |
| Kerendia | 15 | $23,754 | $1,584 |
| Veltassa | 13 | $20,235 | $1,557 |
| Cinacalcet | 19 | $16,032 | $844 |
| Sevelamer Carbonate | 22 | $11,048 | $502 |
| Clinolipid | 18 | $5,071 | $282 |
| Prosol | 18 | $2,177 | $121 |
| Losartan | 104 | $2,001 | $19 |
| Amlodipine Besylate | 92 | $1,320 | $14 |
| Lisinopril | 47 | $1,294 | $28 |
| Hydralazine | 41 | $1,033 | $25 |
| Labetalol | 19 | $1,021 | $54 |
| Furosemide | 94 | $991 | $11 |
| Tamsulosin | 32 | $942 | $29 |
| Gabapentin | 27 | $665 | $25 |
| Allopurinol | 27 | $607 | $22 |
| Terazosin | 12 | $491 | $41 |
| Clonidine | 19 | $448 | $24 |
| Nifedipine Er | 12 | $393 | $33 |
| Calcitriol | 16 | $380 | $24 |
| Atorvastatin | 14 | $286 | $20 |
| Spironolactone | 23 | $232 | $10 |
| Carvedilol | 32 | $229 | $7 |
| Prednisone | 16 | $145 | $9 |
| Pantoprazole | 12 | $116 | $10 |
| Metoprolol | 11 | $15 | $1 |
2022: 25 drugs
| Sevelamer Carbonate | 41 | $27,659 | $675 |
| Lokelma | 29 | $25,828 | $891 |
| Cinacalcet | 18 | $20,274 | $1,126 |
| Eliquis | 16 | $12,411 | $776 |
| Kerendia | 11 | $11,500 | $1,045 |
| Midodrine | 14 | $3,753 | $268 |
| Labetalol | 47 | $2,689 | $57 |
| Calcium Acetate | 20 | $2,473 | $124 |
| Prosol | 16 | $2,217 | $139 |
| Losartan | 100 | $914 | $9 |
| Hydralazine | 34 | $771 | $23 |
| Amlodipine Besylate | 98 | $767 | $8 |
| Calcitriol | 23 | $652 | $28 |
| Allopurinol | 35 | $649 | $19 |
| Furosemide | 85 | $647 | $8 |
| Spironolactone | 35 | $611 | $17 |
| Lisinopril | 23 | $565 | $25 |
| Terazosin | 12 | $472 | $39 |
| Tacrolimus | 12 | $458 | $38 |
| Tamsulosin | 25 | $449 | $18 |
| Atorvastatin | 16 | $394 | $25 |
| Pantoprazole | 23 | $360 | $16 |
| Gabapentin | 21 | $335 | $16 |
| Clonidine | 18 | $189 | $11 |
| Metoprolol | 12 | $161 | $13 |
2021: 23 drugs
| Cinacalcet | 17 | $38,675 | $2,275 |
| Lokelma | 35 | $27,734 | $792 |
| Sevelamer Carbonate | 54 | $16,898 | $313 |
| Eliquis | 17 | $9,047 | $532 |
| Tacrolimus | 23 | $4,534 | $197 |
| Labetalol | 64 | $3,709 | $58 |
| Calcium Acetate | 21 | $2,097 | $100 |
| Losartan | 91 | $1,188 | $13 |
| Hydralazine | 48 | $1,149 | $24 |
| Calcitriol | 27 | $976 | $36 |
| Furosemide | 89 | $776 | $9 |
| Spironolactone | 38 | $683 | $18 |
| Amlodipine Besylate | 97 | $634 | $7 |
| Allopurinol | 32 | $561 | $18 |
| Lisinopril | 34 | $425 | $12 |
| Lactulose | 14 | $423 | $30 |
| Potassium Chloride | 11 | $309 | $28 |
| Tamsulosin | 11 | $240 | $22 |
| Clonidine | 16 | $177 | $11 |
| Pantoprazole | 12 | $133 | $11 |
| Gabapentin | 13 | $106 | $8 |
| Metoprolol | 14 | $80 | $6 |
| Metoclopramide | 11 | $77 | $7 |
2020: 22 drugs
| Cinacalcet | 45 | $29,598 | $658 |
| Sevelamer Carbonate | 57 | $14,254 | $250 |
| Calcium Acetate | 24 | $3,785 | $158 |
| Labetalol | 60 | $3,483 | $58 |
| Diovan | 12 | $2,269 | $189 |
| Bumetanide | 13 | $2,226 | $171 |
| Nifedipine Er | 14 | $1,491 | $107 |
| Hydralazine | 45 | $1,125 | $25 |
| Losartan | 86 | $961 | $11 |
| Furosemide | 109 | $852 | $8 |
| Potassium Chloride | 23 | $789 | $34 |
| Calcitriol | 15 | $757 | $50 |
| Amlodipine Besylate | 120 | $753 | $6 |
| Spironolactone | 39 | $582 | $15 |
| Allopurinol | 35 | $510 | $15 |
| Lisinopril | 37 | $397 | $11 |
| Clonidine | 21 | $276 | $13 |
| Ropinirole | 13 | $196 | $15 |
| Omeprazole | 17 | $136 | $8 |
| Gabapentin | 14 | $102 | $7 |
| Metoprolol | 20 | $71 | $4 |
| Prednisone | 13 | $51 | $4 |
2019: 26 drugs
| Renvela | 18 | $36,557 | $2,031 |
| Sevelamer Carbonate | 59 | $35,216 | $597 |
| Cinacalcet | 23 | $16,333 | $710 |
| Veltassa | 13 | $11,226 | $864 |
| Labetalol | 81 | $6,053 | $75 |
| Calcium Acetate | 22 | $4,362 | $198 |
| Diovan | 12 | $2,309 | $192 |
| Calcitriol | 51 | $1,511 | $30 |
| Nifedipine Er | 15 | $1,418 | $95 |
| Losartan | 100 | $1,234 | $12 |
| Amlodipine Besylate | 149 | $1,227 | $8 |
| Hydralazine | 50 | $1,014 | $20 |
| Tacrolimus | 12 | $885 | $74 |
| Furosemide | 129 | $812 | $6 |
| Potassium Chloride | 19 | $803 | $42 |
| Spironolactone | 49 | $606 | $12 |
| Gabapentin | 13 | $572 | $44 |
| Lisinopril | 48 | $490 | $10 |
| Clonidine | 31 | $389 | $13 |
| Allopurinol | 19 | $269 | $14 |
| Amiloride | 13 | $209 | $16 |
| Tamsulosin | 12 | $196 | $16 |
| Ropinirole | 11 | $175 | $16 |
| Carvedilol | 12 | $131 | $11 |
| Prednisone | 23 | $122 | $5 |
| Metoprolol | 12 | $68 | $6 |
2018: 35 drugs
| Renvela | 58 | $108,652 | $1,873 |
| Sevelamer Carbonate | 57 | $58,594 | $1,028 |
| Veltassa | 13 | $10,285 | $791 |
| Calcium Acetate | 51 | $5,451 | $107 |
| Labetalol | 102 | $5,403 | $53 |
| Spiriva | 11 | $4,362 | $397 |
| Potassium Chloride | 27 | $2,702 | $100 |
| Clonidine | 24 | $2,324 | $97 |
| Cyclosporine Modified | 13 | $2,103 | $162 |
| Losartan | 130 | $1,503 | $12 |
| Amlodipine Besylate | 199 | $1,409 | $7 |
| Nifedipine Er | 21 | $1,327 | $63 |
| Calcitriol | 35 | $1,251 | $36 |
| Hydralazine | 91 | $1,228 | $13 |
| Sodium Polystyrene Sulfonate | 12 | $906 | $75 |
| Furosemide | 157 | $901 | $6 |
| Midodrine | 19 | $871 | $46 |
| Clonidine | 77 | $768 | $10 |
| Lisinopril | 73 | $717 | $10 |
| Spironolactone | 67 | $621 | $9 |
| Atorvastatin | 26 | $485 | $19 |
| Gabapentin | 29 | $483 | $17 |
| Metolazone | 15 | $419 | $28 |
| Pantoprazole | 25 | $368 | $15 |
| Valsartan | 16 | $330 | $21 |
| Metoprolol | 18 | $313 | $17 |
| Terazosin | 13 | $256 | $20 |
| Isosorbide Mononitrate Er | 11 | $234 | $21 |
| Allopurinol | 14 | $207 | $15 |
| Amiloride | 11 | $192 | $17 |
| Ondansetron | 15 | $152 | $10 |
| Prednisone | 17 | $133 | $8 |
| Metoprolol | 21 | $125 | $6 |
| Simvastatin | 16 | $115 | $7 |
| Carvedilol | 16 | $64 | $4 |
2017: 42 drugs
| Renvela | 150 | $275,756 | $1,838 |
| Sensipar | 80 | $128,644 | $1,608 |
| Calcium Acetate | 70 | $8,244 | $118 |
| Labetalol | 104 | $4,731 | $45 |
| Spiriva | 12 | $4,417 | $368 |
| Klor-Con Sprinkle | 12 | $2,981 | $248 |
| Clonidine | 20 | $2,185 | $109 |
| Calcitriol | 37 | $1,826 | $49 |
| Isosorbide Dinitrate | 12 | $1,571 | $131 |
| Amlodipine Besylate | 192 | $1,510 | $8 |
| Nifedipine Er | 23 | $1,401 | $61 |
| Midodrine | 34 | $1,349 | $40 |
| Sodium Polystyrene Sulfonate | 14 | $1,343 | $96 |
| Losartan | 148 | $1,285 | $9 |
| Potassium Chloride | 22 | $1,216 | $55 |
| Hydralazine | 98 | $1,013 | $10 |
| Furosemide | 185 | $1,001 | $5 |
| Valsartan | 27 | $880 | $33 |
| Atorvastatin | 52 | $819 | $16 |
| Clonidine | 80 | $700 | $9 |
| Tacrolimus | 13 | $594 | $46 |
| Minoxidil | 37 | $583 | $16 |
| Metoprolol | 33 | $532 | $16 |
| Metolazone | 11 | $509 | $46 |
| Spironolactone | 40 | $442 | $11 |
| Lisinopril | 78 | $410 | $5 |
| Ropinirole | 24 | $322 | $13 |
| Hydroxyzine | 12 | $305 | $25 |
| Allopurinol | 20 | $298 | $15 |
| Terazosin | 16 | $296 | $19 |
| Nitrofurantoin | 11 | $270 | $25 |
| Pantoprazole | 22 | $267 | $12 |
| Enalapril Maleate | 11 | $242 | $22 |
| Simvastatin | 29 | $225 | $8 |
| Isosorbide Mononitrate Er | 12 | $219 | $18 |
| Metoprolol | 50 | $218 | $4 |
| Gabapentin | 24 | $200 | $8 |
| Metoclopramide | 18 | $160 | $9 |
| Omeprazole | 21 | $132 | $6 |
| Levothyroxine | 12 | $130 | $11 |
| Prednisone | 16 | $126 | $8 |
| Levetiracetam | 12 | $89 | $7 |
2016: 33 drugs
| Renvela | 136 | $247,619 | $1,821 |
| Sensipar | 105 | $130,542 | $1,243 |
| Calcium Acetate | 62 | $6,910 | $111 |
| Potassium Chloride | 35 | $4,341 | $124 |
| Labetalol | 102 | $4,202 | $41 |
| Valsartan | 35 | $1,764 | $50 |
| Amlodipine Besylate | 165 | $1,202 | $7 |
| Nifedipine Er | 21 | $1,162 | $55 |
| Atorvastatin | 56 | $1,055 | $19 |
| Calcitriol | 32 | $995 | $31 |
| Furosemide | 182 | $959 | $5 |
| Losartan | 111 | $895 | $8 |
| Hydralazine | 59 | $860 | $15 |
| Minoxidil | 32 | $607 | $19 |
| Tamsulosin | 22 | $453 | $21 |
| Doxazosin Mesylate | 16 | $444 | $28 |
| Nifedical Xl | 14 | $438 | $31 |
| Metoprolol | 78 | $436 | $6 |
| Midodrine | 13 | $429 | $33 |
| Enalapril Maleate | 15 | $406 | $27 |
| Terazosin | 20 | $401 | $20 |
| Lisinopril | 75 | $401 | $5 |
| Clonidine | 53 | $305 | $6 |
| Isosorbide Mononitrate Er | 14 | $302 | $22 |
| Ondansetron | 17 | $298 | $18 |
| Metoprolol | 18 | $275 | $15 |
| Omeprazole | 25 | $178 | $7 |
| Gabapentin | 25 | $174 | $7 |
| Allopurinol | 14 | $141 | $10 |
| Simvastatin | 27 | $111 | $4 |
| Hydrochlorothiazide | 16 | $81 | $5 |
| Carvedilol | 17 | $66 | $4 |
| Glipizide | 12 | $29 | $2 |
2015: 36 drugs
| Renvela | 150 | $268,263 | $1,788 |
| Sensipar | 136 | $154,006 | $1,132 |
| Fosrenol | 14 | $18,612 | $1,329 |
| Calcium Acetate | 54 | $6,226 | $115 |
| Labetalol | 99 | $5,021 | $51 |
| Valsartan | 25 | $4,207 | $168 |
| Potassium Chloride | 31 | $4,093 | $132 |
| Cyclosporine Modified | 12 | $1,863 | $155 |
| Nifedipine Er | 23 | $1,696 | $74 |
| Amlodipine Besylate | 226 | $1,556 | $7 |
| Hydralazine | 86 | $1,467 | $17 |
| Atorvastatin | 48 | $1,011 | $21 |
| Losartan | 90 | $900 | $10 |
| Furosemide | 162 | $867 | $5 |
| Minoxidil | 58 | $772 | $13 |
| Tamsulosin | 24 | $730 | $30 |
| Lisinopril | 82 | $534 | $7 |
| Calcitriol | 29 | $492 | $17 |
| Metoprolol | 74 | $475 | $6 |
| Enalapril Maleate | 16 | $453 | $28 |
| Allopurinol | 41 | $452 | $11 |
| Midodrine | 11 | $445 | $40 |
| Clonidine | 72 | $439 | $6 |
| Isosorbide Mononitrate Er | 24 | $397 | $17 |
| Nifedical Xl | 13 | $396 | $30 |
| Gabapentin | 32 | $220 | $7 |
| Metoprolol | 13 | $180 | $14 |
| Triamterene-Hydrochlorothiazid | 17 | $176 | $10 |
| Metoclopramide | 19 | $157 | $8 |
| Simvastatin | 25 | $152 | $6 |
| Hydrochlorothiazide | 27 | $126 | $5 |
| Omeprazole | 19 | $121 | $6 |
| Glipizide | 29 | $110 | $4 |
| Pantoprazole | 11 | $106 | $10 |
| Clopidogrel | 17 | $82 | $5 |
| Carvedilol | 17 | $66 | $4 |
2014: 35 drugs
| Renvela | 138 | $187,349 | $1,358 |
| Sensipar | 161 | $128,042 | $795 |
| Fosrenol | 18 | $14,326 | $796 |
| Calcium Acetate | 74 | $9,585 | $130 |
| Labetalol | 91 | $5,804 | $64 |
| Diovan | 21 | $5,720 | $272 |
| Nifedipine Er | 50 | $3,555 | $71 |
| Cyclosporine Modified | 14 | $2,672 | $191 |
| Amlodipine Besylate | 217 | $1,739 | $8 |
| Calcitriol | 32 | $1,716 | $54 |
| Hydralazine | 62 | $1,494 | $24 |
| Losartan | 97 | $1,126 | $12 |
| Lisinopril | 130 | $906 | $7 |
| Clonidine | 80 | $669 | $8 |
| Furosemide | 132 | $648 | $5 |
| Metoprolol | 20 | $636 | $32 |
| Atorvastatin | 32 | $633 | $20 |
| Nifedical Xl | 17 | $503 | $30 |
| Megestrol Acetate | 12 | $486 | $41 |
| Metoprolol | 57 | $480 | $8 |
| Minoxidil | 41 | $433 | $11 |
| Omeprazole | 36 | $422 | $12 |
| Simvastatin | 42 | $341 | $8 |
| Enalapril Maleate | 19 | $281 | $15 |
| Tamsulosin | 14 | $260 | $19 |
| Isosorbide Mononitrate Er | 11 | $225 | $20 |
| Carvedilol | 25 | $210 | $8 |
| Lactulose | 11 | $172 | $16 |
| Pantoprazole | 16 | $154 | $10 |
| Lorazepam | 22 | $139 | $6 |
| Triamterene-Hydrochlorothiazid | 13 | $104 | $8 |
| Gabapentin | 12 | $102 | $8 |
| Allopurinol | 24 | $101 | $4 |
| Hydrochlorothiazide | 12 | $76 | $6 |
| Metoclopramide | 12 | $73 | $6 |
2013: 35 drugs
| Renvela | 123 | $122,164 | $993 |
| Sensipar | 139 | $91,934 | $661 |
| Calcium Acetate | 110 | $11,328 | $103 |
| Fosrenol | 14 | $11,031 | $788 |
| Diovan | 19 | $7,569 | $398 |
| Uloric | 11 | $4,063 | $369 |
| Nifedipine Er | 63 | $3,722 | $59 |
| Labetalol | 52 | $3,084 | $59 |
| Clonidine | 17 | $2,509 | $148 |
| Amlodipine Besylate | 239 | $2,210 | $9 |
| Colcrys | 14 | $2,206 | $158 |
| Calcitriol | 41 | $2,057 | $50 |
| Losartan | 102 | $1,556 | $15 |
| Hydralazine | 43 | $1,226 | $29 |
| Humulin 70-30 | 12 | $1,088 | $91 |
| Lisinopril | 120 | $1,040 | $9 |
| Clonidine | 90 | $891 | $10 |
| Furosemide | 151 | $879 | $6 |
| Kionex | 11 | $723 | $66 |
| Fenofibrate | 15 | $618 | $41 |
| Lidocaine-Prilocaine | 17 | $561 | $33 |
| Minoxidil | 31 | $532 | $17 |
| Metoprolol | 54 | $532 | $10 |
| Omeprazole | 37 | $504 | $14 |
| Carvedilol | 36 | $474 | $13 |
| Potassium Chloride | 16 | $343 | $21 |
| Simvastatin | 43 | $313 | $7 |
| Enalapril Maleate | 12 | $199 | $17 |
| Pramipexole Dihydrochloride | 11 | $135 | $12 |
| Triamterene-Hctz | 13 | $106 | $8 |
| Metoclopramide | 13 | $100 | $8 |
| Pantoprazole | 14 | $99 | $7 |
| Allopurinol | 19 | $97 | $5 |
| Glipizide | 12 | $81 | $7 |
| Lorazepam | 12 | $81 | $7 |
Money from drug and device companies
$241 in 2025
| 2025 | 8 | 11 | None | $241 |
| 2024 | 11 | 20 | None | $462 |
| 2023 | 10 | 21 | None | $486 |
| 2022 | 8 | 22 | None | $652 |
| 2021 | 5 | 8 | None | $245 |
| 2020 | 2 | 4 | $450 | $500 |
| 2019 | 4 | 8 | None | $357 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ANI Pharmaceuticals | Purified Cortrophin Gel | $55 | 3 payments
|
| Calliditas Therapeutics US | Tarpeyo | $38 | 2 payments
|
| Novartis Pharmaceuticals | Fabhalta | $35 | 1 payment
|
| DePuy Synthes Sales | Trufill | $28 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $23 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $22 | 1 payment
|
See all 11 published payments
| Otsuka America Pharmaceutical | Meals · 2025-12-11 | Jynarque | $22 |
| Calliditas Therapeutics US | Meals · 2025-12-04 | Tarpeyo | $22 |
| Calliditas Therapeutics US | Meals · 2025-11-13 | Tarpeyo | $16 |
| DePuy Synthes Sales | Meals · 2025-08-19 | Trufill | $28 |
| ANI Pharmaceuticals | Meals · 2025-06-10 | Purified Cortrophin Gel | $17 |
| ANI Pharmaceuticals | Meals · 2025-04-28 | Purified Cortrophin Gel | $22 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-03-04 | None | $22 |
| ANI Pharmaceuticals | Meals · 2025-03-04 | Purified Cortrophin Gel | $16 |
| Novartis Pharmaceuticals | Meals · 2025-02-24 | Fabhalta | $35 |
| Veloxis Pharmaceuticals | Meals · 2025-02-03 | Envarsus | $18 |
| Mallinckrodt Hospital Products | Meals · 2025-01-22 | Acthar | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $462
| Amgen | Tavneos | $136 | 5 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $56 | 2 payments
|
| Calliditas Therapeutics US | Tarpeyo | $53 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $44 | 2 payments
|
| Novartis Pharmaceuticals | None | $42 | 2 payments
|
| Otsuka America Pharmaceutical | Jynarque | $40 | 2 payments
|
| Lilly USA | Jardiance | $23 | 1 payment
|
| Novo Nordisk | Ozempic | $20 | 1 payment
|
| OPKO Pharmaceuticals | Rayaldee | $18 | 1 payment
|
| Otsuka Pharmaceutical Development & Commercialization | None | $16 | 1 payment
|
| Ardelyx | Ibsrela | $14 | 1 payment
|
2023: $486
| Otsuka America Pharmaceutical | Jynarque | $104 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $84 | 4 payments
|
| Horizon Therapeutics plc | Krystexxa | $69 | 3 payments
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $55 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $45 | 2 payments
|
| GlaxoSmithKline | Benlysta | $42 | 2 payments
|
| Amgen | Epogen | $34 | 1 payment
|
| Otsuka Pharmaceutical Development & Commercialization | Jynarque | $21 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $19 | 1 payment
|
| Fresenius USA Marketing | Velphoro | $13 | 1 payment
|
2022: $652
| Bayer HealthCare Pharmaceuticals | Kerendia | $220 | 5 payments
|
| Amgen | Tavneos | $151 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $131 | 8 payments
|
| Calliditas Therapeutics US | Tarpeyo | $44 | 2 payments
|
| Vifor Pharma | Veltassa | $36 | 2 payments
|
| Horizon Therapeutics plc | Krystexxa | $24 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $24 | 1 payment
|
| GlaxoSmithKline | Benlysta | $22 | 1 payment
|
2021: $245
| Bayer HealthCare Pharmaceuticals | Kerendia | $124 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $53 | 3 payments
|
| Daiichi Sankyo | Injectafer | $25 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $23 | 1 payment
|
| Fresenius USA Marketing | Velphoro | $21 | 1 payment
|
2020: $500
| Becton Dickinson and | None | $450 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $50 | 3 payments
|
2019: $357
| Fresenius USA Marketing | Velphoro | $270 | 4 payments
|
| AngioDynamics | None | $33 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $30 | 2 payments
|
| Alexion Pharmaceuticals | Soliris | $24 | 1 payment
|
Professional record
- NPI
- 1326024084
- Licence
- CA A74682California A74682: Current · expires 2027-02-28
- Trained
- Howard University College of Medicine, 1999
- Group
- West Coast Kidney
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 20055 Lake Chabot Rd, Castro Valley, CA, 94546
- NPI first listed
- 2005-12-15
- NPI last updated
- 2009-07-20
This is when the NPI record was last certified, not a medical board exam.